Survival and prognostic factors in Chinese patients with osteosarcoma: 13-year experience in 365 patients treated at a single institution-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Survival and prognostic factors in Chinese patients with osteosarcoma: 13-year experience in 365 patients treated at a single institution

Published:2017-02 Issue:2 Volume:213 Page:119-125
ISSN:0344-0338
Container-title:Pathology - Research and Practice
language:en
Short-container-title:Pathology - Research and Practice

Author:

Wang Wei,Yang Jing,Wang Yun,Wang Dianjun,Han Gang,Jia Jinpeng,Xu Meng,Bi Wenzhi

Funder

Supporting Research Program

Publisher

Elsevier BV

Subject

Cell Biology,Pathology and Forensic Medicine

Reference28 articles.

1. Osteosarcoma

2. Osteosarcoma incidence and survival rates from 1973 to 2004: data from the surveillance, epidemiology, and end results program;Mirabello;Cancer,2009

3. The evolving classification of soft tissue tumours – an update based on the new 2013 WHO classification;Fletcher;Histopathology,2014

4. Does the histological subtype of high-grade central osteosarcoma influence the response to treatment with chemotherapy and does it affect overall survival? A study on 570 patients of two consecutive trials of the European Osteosarcoma Intergroup;Hauben;Eur. J. Cancer,2002

5. Primary osteosarcoma of bone. Clinicopathologic investigation of 243 cases, with necropsy studies in 54;Uribe-Botero;Am. J. Clin. Pathol.,1977

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The combination of apatinib and antigen-specific DC-induced T cells exert antitumor effects by potently improving the immune microenvironment of osteosarcoma;Heliyon;2024-08

2. Survival and prognostic factors in pediatric osteosarcoma: A 5-year single-center experience in Central Java, Indonesia;Paediatrica Indonesiana;2024-02-20

3. The effect of doxorubicin curcumin co-loaded lipid nanoparticles and doxorubicin on osteosarcoma before surgery;Cancer Nanotechnology;2024-01-31

4. Sulfatinib, a novel multi-targeted tyrosine kinase inhibitor of FGFR1, CSF1R, and VEGFR1–3, suppresses osteosarcoma proliferation and invasion via dual role in tumor cells and tumor microenvironment;Frontiers in Oncology;2023-06-08

5. Surgical resection of primary tumors improves survival in patients with lung metastases: a population-based SEER analysis;Translational Cancer Research;2023-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3